AtaiBeckley (XTER:B72) FFO


XTER:B72 AtaiBeckley Inc XTER:B72
53 GF Score
Price €3.84
GF Value €5.42
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is AtaiBeckley FFO?

FFO (Funds from operations) only applies to REITs.

XTER:B72
53GF Score
AtaiBeckley Inc XTER:B72
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AtaiBeckley (XTER:B72) Overvalued in 2026?

Based on GuruFocus' analysis, AtaiBeckley stock appears to be undervalued. The current stock price of €3.84 is trading 29.2% below its estimated GF Value™ of €5.42. GuruFocus considers AtaiBeckley to be Possible Value Trap.

Key valuation signals for XTER:B72:

  • FFO:
  • GF Value™: €5.42 vs. price of €3.84 (29.2% below fair value)
  • GF Score™: 53/100 with 5 warning signs

No single metric tells the full story. See the XTER:B72 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AtaiBeckley Business Description

Other Exchanges ATAI:USA
Address 250 West 34th Street, New York, NY, USA, 10119
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
53GF Score

Get the complete analysis for XTER:B72

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.84
Price
€5.42
GF Value